Free Trial

RTW Biotech Opportunities (RTW) Competitors

RTW Biotech Opportunities logo
GBX 1.22 +0.01 (+0.83%)
As of 11:46 AM Eastern

RTW vs. WTAN, RAT, FEV, BRW, MYI, BHMU, SNN, WWH, JTC, and FGT

Should you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include Witan Investment Trust (WTAN), Rathbones Group (RAT), Fidelity European Trust (FEV), Brewin Dolphin (BRW), Murray International (MYI), BH Macro USD (BHMU), Sanne Group (SNN), Worldwide Healthcare (WWH), JTC (JTC), and Finsbury Growth & Income (FGT). These companies are all part of the "asset management" industry.

RTW Biotech Opportunities vs.

Witan Investment Trust (LON:WTAN) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

In the previous week, RTW Biotech Opportunities had 1 more articles in the media than Witan Investment Trust. MarketBeat recorded 1 mentions for RTW Biotech Opportunities and 0 mentions for Witan Investment Trust. Witan Investment Trust's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
Witan Investment Trust Neutral
RTW Biotech Opportunities Neutral

Witan Investment Trust received 93 more outperform votes than RTW Biotech Opportunities when rated by MarketBeat users. However, 100.00% of users gave RTW Biotech Opportunities an outperform vote while only 67.63% of users gave Witan Investment Trust an outperform vote.

CompanyUnderperformOutperform
Witan Investment TrustOutperform Votes
94
67.63%
Underperform Votes
45
32.37%
RTW Biotech OpportunitiesOutperform Votes
1
100.00%
Underperform Votes
No Votes

8.5% of Witan Investment Trust shares are held by institutional investors. Comparatively, 3.9% of RTW Biotech Opportunities shares are held by institutional investors. 8.2% of Witan Investment Trust shares are held by insiders. Comparatively, 16.2% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Witan Investment Trust has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, RTW Biotech Opportunities has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.

RTW Biotech Opportunities has a net margin of 664.38% compared to Witan Investment Trust's net margin of 89.43%. RTW Biotech Opportunities' return on equity of 25.18% beat Witan Investment Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Witan Investment Trust89.43% 13.68% 7.95%
RTW Biotech Opportunities 664.38%25.18%-0.47%

RTW Biotech Opportunities has higher revenue and earnings than Witan Investment Trust. Witan Investment Trust is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Witan Investment Trust£246.38M0.00£220.34M£0.36N/A
RTW Biotech Opportunities£2.12B0.19£14.09B£0.422.91

Summary

RTW Biotech Opportunities beats Witan Investment Trust on 8 of the 13 factors compared between the two stocks.

Get RTW Biotech Opportunities News Delivered to You Automatically

Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RTW vs. The Competition

MetricRTW Biotech OpportunitiesAsset Management IndustryFinancial SectorLON Exchange
Market Cap£409.82M£1.16B£3.85B£2.59B
Dividend YieldN/A4.46%4.21%4.97%
P/E Ratio2.9121.6512.97133.69
Price / Sales0.192,296.061,700.09239,757.82
Price / Cash0.3261.2950.3828.12
Price / Book0.011.123.404.55
Net Income£14.09B£262.20M£1.24B£5.84B
7 Day PerformanceN/A1.35%1.14%3.43%
1 Month Performance2.95%5.67%10.87%10.59%
1 Year Performance-7.58%2.70%12.63%117.06%

RTW Biotech Opportunities Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RTW
RTW Biotech Opportunities
N/AGBX 1.22
+0.8%
N/A-7.7%£409.82M£2.12B2.914,971News Coverage
WTAN
Witan Investment Trust
N/AN/AN/AN/A£1.58B£246.38M738.896
RAT
Rathbones Group
2.9117 of 5 stars
GBX 1,520
+1.1%
N/A-3.0%£1.58B£874.75M24.743,500Analyst Forecast
High Trading Volume
FEV
Fidelity European Trust
N/AGBX 383.50
+2.3%
N/A+1.3%£1.58B£221.98M7.60N/A
BRW
Brewin Dolphin
N/AN/AN/AN/A£1.56B£415.46M3,029.412,186
MYI
Murray International
N/AGBX 258
+1.6%
N/A+6.8%£1.54B£198.15M8.58N/ADividend Announcement
News Coverage
BHMU
BH Macro USD
N/AGBX 4.07
-0.8%
N/A+8.6%£1.51B£2.88B34.95N/AHigh Trading Volume
SNN
Sanne Group
N/AN/AN/AN/A£1.50B£194.16M-204.6720,100
WWH
Worldwide Healthcare
N/AGBX 281.50
+3.1%
N/A-15.0%£1.50B£245.62M6.55N/ANews Coverage
Positive News
High Trading Volume
JTC
JTC
2.8894 of 5 stars
GBX 827
+2.5%
GBX 1,400
+69.3%
-1.5%£1.39B£291.42M46.381,603
FGT
Finsbury Growth & Income
N/AGBX 895.34
+1.1%
N/A+9.7%£1.33B£101.41M14.71N/ANews Coverage
Positive News

Related Companies and Tools


This page (LON:RTW) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners